Estimates of EFS and survival in 312 children with

Childhood high-risk acute lymphoblastic leukemia in first
remission: results after chemotherapy or transplant from
the AIEOP ALL 2000 study
by Valentino Conter, Maria Grazia Valsecchi, Rosanna Parasole, Maria Caterina
Putti, Franco Locatelli, Elena Barisone, Luca Lo Nigro, Nicola Santoro, Maurizio
Aricò, Ottavio Ziino, Andrea Pession, Anna Maria Testi, Concetta Micalizzi, Fiorina
Casale, Marco Zecca, Gabriella Casazza, Paolo Tamaro, Gaetano La Barba, Lucia
Dora Notarangelo, Daniela Silvestri, Antonella Colombini, Carmelo Rizzari, Andrea
Biondi, Giuseppe Masera, and Giuseppe Basso
Blood
Volume 123(10):1470-1478
March 6, 2014
©2014 by American Society of Hematology
Estimates of EFS and survival in 312 children with ALL classified as HR in the AIEOP-BFM 2000
protocol and treated in AIEOP centers.
Valentino Conter et al. Blood 2014;123:1470-1478
©2014 by American Society of Hematology
Estimates of EFS in 312 children with HR-ALL by HR criteria (hierarchical order).
Valentino Conter et al. Blood 2014;123:1470-1478
©2014 by American Society of Hematology
Outcome of HR-ALL children eligible for HSCT in first remission and treated with HSCT or
chemotherapy only.
Valentino Conter et al. Blood 2014;123:1470-1478
©2014 by American Society of Hematology